ZTS · 10-Q · 2026Q2 · Full report

Macroeconomic Consumer Pressure

Zoetis Inc. · 2026-08-06 · Importance 60 · Surprise 40

U.S. companion-animal revenue declined by $240 million, or 11%, in the six months ended June 30, 2026. Zoetis attributed the decline partly to softer end-market demand, heightened competition and macroeconomic-driven price sensitivity affecting its key dermatology franchise and Simparica Trio. The company also reported generic competition affecting Convenia and Cerenia and lower Librela sales, while U.S. segment revenue declined $183 million, or 7%.

Key facts

• Quarterly financial results are subject to variability including tariffs and other trade protection measures, the decline in global macroeconomic conditions, competitive dynamics, geopolitical tensions, inflation, global supply chain disruption and supply availability, variability in distributor inventory stocking levels, weather patterns, herd management decisions, regulatory actions, disease outbreaks, product and geographic mix, timing of price increases and customer expectations, timing of investment decisions and operational and other changes made in connection with the change in accounting principle to eliminate the one-month financial reporting lag in 2026 for our subsidiaries operating outside the U.S. source